Cargando...
Therapy-activated stromal cells can dictate tumor fate
In this issue of JEM, Chan et al. describe a novel way by which an investigational form of chemotherapy known as low-dose metronomic chemotherapy can inhibit tumor growth, which also has therapeutic implications for targeting tumor-initiating cells (TICs), the tumor stroma, and chemokine receptors,...
Guardado en:
| Publicado en: | J Exp Med |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
The Rockefeller University Press
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5154951/ https://ncbi.nlm.nih.gov/pubmed/27881735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20161845 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|